No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10430939 |
chr11:3933564-3933565 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs536758365 |
chr11:3933618-3933619 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs111851528 |
chr11:3933626-3933627 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs191456523 |
chr11:3933636-3933637 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs543049425 |
chr11:3933683-3933684 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs564000856 |
chr11:3933712-3933713 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs534901634 |
chr11:3933758-3933759 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs532839735 |
chr11:3933776-3933777 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs546486673 |
chr11:3933787-3933788 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs553332507 |
chr11:3933793-3933794 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs184658797 |
chr11:3933812-3933813 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs543008784 |
chr11:3933842-3933843 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs561273397 |
chr11:3933843-3933844 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs576557477 |
chr11:3933866-3933867 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs190765811 |
chr11:3933885-3933886 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs73425461 |
chr11:3933950-3933951 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs532633082 |
chr11:3934002-3934003 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs73425465 |
chr11:3934028-3934029 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs112634377 |
chr11:3934067-3934068 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs192856198 |
chr11:3934090-3934091 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs530345323 |
chr11:3934091-3934092 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs9988893 |
chr11:3934108-3934109 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs10767702 |
chr11:3934132-3934133 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
24 |
rs185355706 |
chr11:3934165-3934166 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs10835285 |
chr11:3934185-3934186 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs552027975 |
chr11:3934206-3934207 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs73425467 |
chr11:3934209-3934210 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs139081347 |
chr11:3934220-3934221 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs553218329 |
chr11:3934243-3934244 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs149837701 |
chr11:3934295-3934296 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs58280202 |
chr11:3934328-3934329 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs145808886 |
chr11:3934329-3934330 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs576396717 |
chr11:3934333-3934334 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs544212711 |
chr11:3934344-3934345 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs558815092 |
chr11:3934411-3934412 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs7122796 |
chr11:3934429-3934430 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs368830418 |
chr11:3934451-3934452 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs541234222 |
chr11:3934517-3934518 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs559531189 |
chr11:3934521-3934522 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs530283818 |
chr11:3934552-3934553 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs113640980 |
chr11:3934563-3934564 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs60166118 |
chr11:3934584-3934585 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs542163354 |
chr11:3934665-3934666 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs140723361 |
chr11:3934697-3934698 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs530450708 |
chr11:3934747-3934748 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs145869313 |
chr11:3934772-3934773 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs570416810 |
chr11:3934793-3934794 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs189416171 |
chr11:3934838-3934839 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs546768440 |
chr11:3934851-3934852 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs568306631 |
chr11:3934900-3934901 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|